Skip to content

The influence of stress on cognitive functioning in Parkinson*s disease

The influence of stress on cognitive functioning in Parkinson*s disease - Stress and cognitive functioning in Parkinson

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON37748
Enrollment
204
Registered
2012-05-01
Start date
2012-08-02
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

mental processes Psychological disstress

Interventions

None listed

Sponsors

Atrium Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Parkinson's Disease according to the UKPDS Brain Bank Criteria as diagnosed by a neurologist. - Stabel dosage of "anti-parkinsonian" medication at onset of the study

Exclusion criteria

Exclusion criteria: - Surgical treatment for PD, such as deep brain stimulation. - Suspected dementia at the onset of the study. - Presence of co-morbid neurological disorder (e.g. CVA) or infection (e.g. meningitis) within last 5 years other than PD that influences cognitive functioning. - Medication (e.g. corticosteroid) that influences daily cortisol levels. - Presence of posttraumatic stress disorder and/or psychotic disorders which influences cognitive functioning. - Depression according to the Beck Depression Inventory (BDI), cut-off score 15 for PD patients and cut-off score 10 for healthy controls.

Design outcomes

Primary

MeasureTime frame
Different parameters for stress will be taken into account (cortisol levels, scores on a perceived stress questionnaire). Furthermore, performance on cognitive tasks will be assessed in the PD group and control group. Both groups will be compared with each other. There will be assessed whether: - stress (chronic and acute) influences cognitive functioning in PD - chronic stress is associated with an accelerated cognitive decline in PD

Secondary

MeasureTime frame
Different parameters for stress will be taken into account (induced stress, vulnerability to perceive stress). Furthermore, performance on cognitive tasks as well as medical decision making tasks will be assessed in the PD group and control group. Both groups will be compared with each other. There will be assessed whether: - induced stress influences cognitive functioning in PD - vulnerability to perceive stress moderates the influence of (chronic and acute) stress on cognitive functioning in PD. - cognitive functioning mediates the influence of stress on medical decision making in PD.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)